Last week, Davy Stockbrokers published an in-depth report on DCC Healthcare. The timing was good. The division has had a low profile in the past relative to its size and performance, and the market growth dynamics and opportunities for the business are exciting. DCC is also at a stage in its corporate development when it is likely to be considering several strategic options for its four distinct businesses and for the group as a whole.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team